Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Controlled Randomized Clinical Trial on Using Ivermectin With Doxycycline for Treating COVID-19 Patients in Baghdad, Iraq

NCT04591600 is registered in ClinicalTrials.gov with Alkarkh Health Directorate-Baghdad as lead sponsor.

NCT NCT04591600
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04591600 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Controlled Randomized Clinical Trial on Using Ivermectin With Doxycycline for Treating COVID-19 Patients in Baghdad, Iraq
Lead sponsor
Alkarkh Health Directorate-Baghdad
Phase
Phase 1/2
Overall status
Completed
Start date
July 1, 2020
Completion date
October 14, 2020
Enrollment
140 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19